Dr. Robert Pytlík is a hematologist specializing in the treatment of lymphoproliferative disorders, particularly non-Hodgkin lymphomas and chronic lymphocytic leukemia (CLL). He works at the Institute of Hematology and Blood Transfusion, where he leads the Department of Cellular Therapy. This unit is responsible for the preparation of hematopoietic stem cells for transplantation, as well as the manufacturing and storage of selected advanced therapy medicinal products. He is also the head of the CAR T-cell therapy program.
